UniSuper Management Pty Ltd Sells 100 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

UniSuper Management Pty Ltd lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 5,876 shares of the biotechnology company’s stock after selling 100 shares during the period. UniSuper Management Pty Ltd’s holdings in Axon Enterprise were worth $3,492,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Prestige Wealth Management Group LLC grew its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise during the third quarter valued at about $41,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise during the fourth quarter worth about $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter worth about $53,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $534.95 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a market capitalization of $40.99 billion, a P/E ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm’s 50 day moving average is $589.62 and its 200 day moving average is $547.97.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AXON. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Finally, Needham & Company LLC reissued a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.